Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,000
Total Claims
$2.2M
Drug Cost
1,512
Beneficiaries
$1,471
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
-4%
Cost per patient vs peers
$1,471 vs $1,524 avg
-9%
Brand preference vs peers
12.4% vs 13.7% avg
Opioid Prescribing
0.1%
Opioid Rate
14
Opioid Claims
$56
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,986 claims · $1.8M
Generic: 14,000 claims · $377K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 840 | $889K |
| Rivaroxaban | 192 | $213K |
| Evolocumab | 111 | $166K |
| Sacubitril/Valsartan | 86 | $102K |
| Empagliflozin | 91 | $97K |
| Alirocumab | 44 | $61K |
| Dronedarone Hcl | 19 | $42K |
| Pitavastatin Calcium | 59 | $37K |
| Sitagliptin Phosphate | 42 | $35K |
| Ezetimibe | 658 | $26K |
| Semaglutide | 15 | $26K |
| Dapagliflozin Propanediol | 22 | $26K |
| Metoprolol Succinate | 988 | $23K |
| Valsartan | 583 | $23K |
| Ticagrelor | 23 | $22K |
Prescribing Profile
Patient Profile
78
Avg Age
52%
Female
1.24
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data